Cargando…
Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example
INTRODUCTION: Determining the epidemiology of disease is critical for multiple reasons, including to perform risk assessment, compare disease rates in varying populations, support diagnostic decisions, evaluate health care needs and disease burden, and determine the economic benefit of treatment. Ho...
Autores principales: | Kruger, Eliza, McNiven, Paul, Marsden, Deborah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239941/ https://www.ncbi.nlm.nih.gov/pubmed/35674971 http://dx.doi.org/10.1007/s12325-022-02186-2 |
Ejemplares similares
-
Understanding the impact of long-chain fatty acid oxidation disorders for patients and caregivers
por: Kruger, Eliza, et al.
Publicado: (2022) -
Qualitative evaluation of the symptoms and quality of life impacts of
long-chain fatty acid oxidation disorders
por: Williams-Hall, Rebecca, et al.
Publicado: (2022) -
Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders
por: Marsden, Deborah, et al.
Publicado: (2021) -
Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
por: Knottnerus, Suzan J. G., et al.
Publicado: (2018) -
Different Lipid Signature in Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders
por: Alatibi, Khaled I., et al.
Publicado: (2021)